Chimerix, Inc. (CMRX)
NASDAQ: CMRX · Real-Time Price · USD
2.990
+0.140 (4.91%)
At close: Dec 20, 2024, 4:00 PM
3.039
+0.048 (1.62%)
After-hours: Dec 20, 2024, 6:58 PM EST
Chimerix Revenue
Chimerix had revenue of $26.00K in the quarter ending September 30, 2024, with 136.36% growth. This brings the company's revenue in the last twelve months to $159.00K, down -85.98% year-over-year. In the year 2023, Chimerix had annual revenue of $324.00K, down -99.04%.
Revenue (ttm)
$159.00K
Revenue Growth
-85.98%
P/S Ratio
n/a
Revenue / Employee
$2,208
Employees
72
Market Cap
268.91M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 324.00K | -33.50M | -99.04% |
Dec 31, 2022 | 33.82M | 31.85M | 1,609.15% |
Dec 31, 2021 | 1.98M | -3.39M | -63.16% |
Dec 31, 2020 | 5.37M | -7.15M | -57.09% |
Dec 31, 2019 | 12.52M | 5.30M | 73.49% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
TruBridge | 337.67M |
Lifecore Biomedical | 128.44M |
Cidara Therapeutics | 44.65M |
Senseonics Holdings | 22.21M |
Lexicon Pharmaceuticals | 5.23M |
CMRX News
- 10 days ago - Chimerix: Big News, Big Moves, So Maybe Now's The Time To Buy - Seeking Alpha
- 12 days ago - Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End - GlobeNewsWire
- 15 days ago - Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Chimerix, Inc. (CMRX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024 - GlobeNewsWire
- 2 months ago - Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Chimerix, Inc. (CMRX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference - GlobeNewsWire